Glaukos Corporation , an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, plans to release ...
Scientists develop self-propelling nanoparticles that can physically pierce and eliminate drug-resistant bacteria in eye infections, showing success in initial animal studies.